Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if Minocin® (minocycline) can reduce
certain side effects of surgery in patients with head and neck cancer (such as pain, fatigue,
and disturbed sleep). In this study, minocycline will be compared to a placebo.
A placebo is not a drug. It looks like the study drug, but it is not designed to treat any
disease or illness. It is designed to be compared with a study drug to learn if the study
drug has any real effect.